Complementary Roles for Tissue- and Blood-Based Comprehensive Genomic Profiling for Detection of Actionable Driver Alterations in Advanced NSCLC

Autor: Lee S. Schwartzberg, MD, Gerald Li, PhD, Khaled Tolba, MD, Ariel B. Bourla, MD, PhD, Katja Schulze, PhD, Rujuta Gadgil, MS, Alexander Fine, PhD, Katherine T. Lofgren, PhD, Ryon P. Graf, PhD, Geoffrey R. Oxnard, MD, Davey Daniel, MD

Publikováno v: JTO Clinical and Research Reports, Vol 3, Iss 9, Pp 100386- (2022)

Introduction: Whereas tumor biopsy is the reference standard for genomic profiling of advanced NSCLC, there are now multiple assays approved by the Food and Drug Administration for liquid biopsy testing of circulating tumor DNA. Here, we study the in

Externí odkaz: https://doaj.org/article/6ee120b19f7d45749c83a4e3900b99b2

Strategies for the Management of Early-Stage Breast Cancer in Older Women.

Autor: Schwartzberg LS; Presented by Lee S. Schwartzberg, MD, The University of Tennessee Health Science Center, West Cancer Center, Memphis, Tennessee, and Sarah L. Blair, MD, Department of Surgery, University of California San Diego Moores Cancer Center, La Jolla, California., Blair SL; Presented by Lee S. Schwartzberg, MD, The University of Tennessee Health Science Center, West Cancer Center, Memphis, Tennessee, and Sarah L. Blair, MD, Department of Surgery, University of California San Diego Moores Cancer Center, La Jolla, California.

Publikováno v: Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2016 May; Vol. 14 (5 Suppl), pp. 647-50.